DONNA CRICHTON: Open Payments
NPI 1427721620 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,318 in 31 payments from 6 companies in 2025. Trend: 2023 $163 · 2024 $977 · 2025 $1,318
Food & beverage: $1,318
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 3 | $396 |
| Gilead Sciences, Inc. | 10 | $385 |
| Ipsen Biopharmaceuticals, Inc | 3 | $279 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 12 | $175 |
| ORPHALAN INC | 2 | $49 |
| Mallinckrodt Hospital Products Inc. | 1 | $33 |
Products named: REZDIFFRA, IQIRVO, XIFAXAN, Livdelzi, CUVRIOR, TERLIVAZ.
Industry payments across NY — which companies pay providers there.
